COMPOSITION
Active substances in one dose before inactivation:
Porcine epidemic diarrhea virus, strain U-14 > 10^4.0 TCD₅₀/ml.
Excipients: adjuvant SiO2 (A-300) – 10-15 mg per dose.
PHARMACEUTICAL FORM
Suspension.
IMMUNOBIOLOGICAL PROPERTIES
The vaccine stimulates the formation of active immunity against porcine epidemic diarrhea in suckling piglets 14 days after the first intake of colostrum, which persists throughout the entire suckling period. It has no medicinal properties.
ANIMAL SPECIES
Pigs.
INDICATIONS FOR USE
For the prevention of porcine epidemic diarrhea in pigs by developing colostral immunity in suckling piglets.
CONTRAINDICATIONS
Depleted and sick animals should not be vaccinated.
SIDE EFFECTS
In exceptional cases, swelling may occur at the injection site, which disappears without treatment after 1-2 days.
SPECIAL PRECAUTIONS
During long-term storage, the formation of a slightly friable precipitate is possible, which easily disintegrates into a homogeneous suspension when shaken. The vaccine is shaken before administration and heated to 20-25°c.
USE DURING PREGNANCY, LACTATION
Pregnant sows are vaccinated 5-4 and 3-2 weeks before farrowing.
ROUTE OF ADMINISTRATION AND DOSAGE
The vaccine is administered to sows intramuscularly in the behind-the-ear region, 2.0 ml 5-4 and 3-2 weeks before farrowing.
WITHDRAWAL PERIOD
0 days.
PACKAGING AND PRESENTATION
The vaccine in glass bottles of 5, 10, 25, 50, and 100 doses, corked and sealed with aluminum caps.
SHELF LIFE
24 months. Use within 3 hours after the first opening (breaking the seal).
Store the vaccine in a dark place, out of the reach of children, at a temperature of 2 to 8°C, do not freeze!